2-201491228-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001168221.2(C2CD6):c.5113C>A(p.His1705Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000361 in 1,385,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD6 | NM_001168221.2 | c.5113C>A | p.His1705Asn | missense_variant | 15/16 | ENST00000439140.6 | NP_001161693.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD6 | ENST00000439140.6 | c.5113C>A | p.His1705Asn | missense_variant | 15/16 | 1 | NM_001168221.2 | ENSP00000409937.1 | ||
C2CD6 | ENST00000286195.7 | c.1582-3326C>A | intron_variant | 1 | ENSP00000286195.3 | |||||
C2CD6 | ENST00000439802.5 | c.*50-3326C>A | intron_variant | 2 | ENSP00000400672.1 | |||||
C2CD6 | ENST00000482942.1 | n.101-3326C>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000277 AC: 4AN: 144240Hom.: 0 AF XY: 0.0000522 AC XY: 4AN XY: 76690
GnomAD4 exome AF: 0.00000361 AC: 5AN: 1385446Hom.: 0 Cov.: 33 AF XY: 0.00000439 AC XY: 3AN XY: 683610
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.5113C>A (p.H1705N) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a C to A substitution at nucleotide position 5113, causing the histidine (H) at amino acid position 1705 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at